Skip to main content
logo
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
64.01
+1.75 (2.81%)
At close: Aug 4, 2026, 4:00 PM EDT
62.73
-1.28 (-2.00%)
After-hours: Aug 4, 2026, 7:34 PM EDT

Xenon Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-7.5--9.4318.44
Revenue Growth
-----48.83%-42.68%
Gross Profit
-7.5--9.4318.44
Operating Income
-412.66-373.07-279.3-214.05-129.14-78.99
Net Income
-383.17-345.91-234.33-182.39-124.94-77.09
Earnings Per Share
-4.70-4.36-3.01-2.73-2.06-1.77
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,095548.89626.91638.08592.09551.77
Total Debt
7.497.949.0210.910.448.26
Net Cash (Debt)
1,087540.94617.89627.18581.65543.52
Net Cash Growth
100.99%-12.45%-1.48%7.83%7.02%212.94%
Net Cash Per Share
13.356.837.939.389.6112.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-306.36-279.12-181.39-151.11-101.03-69.5
Capital Expenditures
-0.89-0.8-3.08-5.62-2.89-2.05
Free Cash Flow
-307.25-279.92-184.46-156.73-103.92-71.55
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%--100.00%100.00%
Operating Margin
--4974.27%---1368.91%-428.45%
Pretax Margin
--4598.59%---1327.70%-427.88%
Profit Margin
--4612.13%---1328.95%-427.85%
FCF Margin
--3732.23%---1101.57%-388.09%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-21.6521.6521.6521.6521.65
PS Ratio
-478.14--261.5989.21